Abstract
This study was designed to assess the prognostic value of the ratio of metastatic to resected lymph nodes (lymph node ratio [LNR]) in patients with node-positive colorectal cancer (CRC). From May 1998 to December 2007, data from a total of 514 patients who underwent curative surgery for CRC with proven lymph node metastases were analyzed. Patients were categorized into four groups on the basis of quartiles: LNR1 (<0.09), LNR2 (between 0.09 and 0.18), LNR3 (>0.18 and <0.34), and LNR4 (≥0.34). The median numbers of resected and metastatic nodes were 14 (range, 2-67) and 2 (range, 1-31), respectively. With a median follow-up period of 48.5months, the 5-year overall survival rates of patients with LNR1, LNR2, LNR3, and LNR4 were 79, 72, 62, and 55%, respectively (P<0.001); the 5-year disease-free survival rates of patients with LNR1, LNR2, LNR3, and LNR4 were 73, 67, 54, and 42%, respectively (P<0.001). In the multivariate analysis, the LNR was an independent prognostic factor for both overall (P=0.012) and disease-free survival (P=0.009), as were pT and pN category. LNR remained statistically significant both in patients with <12 and with >12 nodes retrieved. In addition to the conventional pT and pN categories, the LNR was a predictor of both the overall and disease-free survival in patients with node-positive CRC. It may compensate for an inadequate lymph node dissection in surgery for CRC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
